Heart Test Laboratories, Inc. (HSCS)
NASDAQ: HSCS · IEX Real-Time Price · USD
4.580
+0.840 (22.46%)
At close: Jul 26, 2024, 4:00 PM
4.450
-0.130 (-2.84%)
After-hours: Jul 26, 2024, 7:23 PM EDT
Heart Test Laboratories Revenue
Heart Test Laboratories had revenue of $14.70K in the quarter ending January 31, 2024, with 653.85% growth. This brings the company's revenue in the last twelve months to $18.60K, up 100.02% year-over-year. In the fiscal year ending April 30, 2023, Heart Test Laboratories had annual revenue of $5.15K, down -64.17%.
Revenue (ttm)
$18.60K
Revenue Growth
+100.02%
P/S Ratio
161.44
Revenue / Employee
$1,550
Employees
12
Market Cap
3.00M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2023 | 5.15K | -9.22K | -64.17% |
Apr 30, 2022 | 14.37K | -11.23K | -43.86% |
Apr 30, 2021 | 25.60K | -38.58K | -60.11% |
Apr 30, 2020 | 64.18K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionHSCS News
- 11 hours ago - Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - GlobeNewsWire
- 1 day ago - HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewsWire
- 15 days ago - HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction - GlobeNewsWire
- 7 weeks ago - HeartSciences Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 2 months ago - HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio - GlobeNewsWire
- 3 months ago - HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG - GlobeNewsWire
- 4 months ago - HeartSciences to Present at the LD Micro Invitational XIV Conference - GlobeNewsWire
- 4 months ago - HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients - GlobeNewsWire